VIKAND, global leader in maritime healthcare, has signed an agreement with MITSUI OCEAN CRUISES, part of the Mitsui O.S.K. Lines. Ltd. group, the most experienced cruise line in Japan, to provide Japanese guests and crew with first class medical services.

VIKAND will recruit, hire and manage a team of medical experts to cater for the needs of up to 458 guests and 330 crew on MITSUI OCEAN CRUISES’ newest luxury vessel called MITSUI OCEAN FUJI, formerly Seabourn Odyssey, which begins service in December this year.

MITSUI OCEAN CRUISES prides itself on giving its guests an authentic Japanese experience, presented by a special and sincere an “omotenashi” service which translated means to give guests a peaceful and relaxing moment filled with joy.

Featuring the praise of delicious cuisine and “FUNATABI” – Beautiful encounters with Japan-, MITSUI OCEAN FUJI is catering to the luxury end of the Japanese market.

The company chose VIKAND to ensure its culture of providing exceptional levels of customer service extended to the medical needs of its guests and crew.

VIKAND will run the onboard medical center, provide standard operating procedures and biomedical equipment support, as well as the supply of formulary to meet all flag state requirements. VIKAND will also provide Japanese speaking medical staff to ensure high quality, seamless service.

“We’re delighted to partner with VIKAND who matches our outstanding levels of customer service to a very discerning customer base,” said Tsunemichi Mukai, President of MITSUI OCEAN CRUISES.

“We are delighted to secure our new partnership with MITSUI OCEAN CRUISES by showcasing our ability to meet the esteemed Japanese standards of excellence and consciousness. All our medical staff have had previous experience at sea so can empathize with crew and guests, affording them the best levels of care. We hope that our dedication to running an efficient medical service on MITSUI OCEAN FUJI will ensure the continued success of the MITSUI OCEAN CRUISES brand,” said Peter Hult, CEO, VIKAND.